HCLTECH.NS Stock Down 0.02% on May 5, 2026 – NSE Trading

HCL Technologies Limited (HCLTECH.NS) traded at ₹1,198.90 on the NSE on May 5, 2026, down 0.02% from the previous close. The IT services giant, headquartered in Noida, operates across software development, business process outsourcing, and infrastructure management globally. With a market cap of ₹3.25 trillion and 2.7 billion shares outstanding, HCLTECH.NS remains a key player in India’s technology sector. The stock showed modest intraday movement within a range of ₹1,190 to ₹1,204.90. Investors track HCLTECH.NS stock for exposure to India’s growing IT services industry and digital transformation trends.

HCLTECH.NS Stock Price and Valuation Metrics

HCLTECH.NS stock trades at a PE ratio of 19.56, suggesting moderate valuation relative to earnings. The stock’s price-to-sales ratio stands at 2.49, indicating investors pay ₹2.49 for every rupee of revenue. Book value per share is ₹277.97, with the stock trading at 4.32 times book value.

The 50-day moving average is ₹1,363.01, while the 200-day average sits at ₹1,506.21, both above current price levels. This suggests the stock has declined from recent highs. Year-to-date, HCLTECH.NS stock has fallen 26.05%, though it remains up 33.25% over five years. The company’s EPS of ₹61.39 reflects solid earnings generation despite market headwinds.

Market Sentiment and Trading Activity

Technical indicators reveal mixed signals for HCLTECH.NS stock. The RSI at 28.80 indicates oversold conditions, suggesting potential bounce-back opportunities. However, the MACD at -55.89 with a signal line of -34.64 points to bearish momentum.

Trading volume remains subdued with only 5,592 shares traded against an average of 4.49 million shares. This represents just 0.12% of average volume, indicating light activity. The ADX at 36.92 confirms a strong downtrend is in place. Liquidation pressure appears evident from the negative OBV at -65.5 million, suggesting more selling than buying interest in recent sessions.

Financial Strength and Growth Trajectory

HCL Technologies demonstrates robust financial health with a debt-to-equity ratio of 0.069, well below sector averages. The company maintains a current ratio of 2.22, indicating strong liquidity to meet short-term obligations. Operating margins stand at 17.24%, while net profit margins reach 12.82%.

Growth metrics show resilience. Net income grew 10.37% year-over-year, with EPS expanding 10.64%. Free cash flow per share is ₹79.10, supporting the dividend of ₹60 per share. The company’s ROE of 23.15% and ROCE of 26.67% demonstrate efficient capital deployment. Track HCLTECH.NS on Meyka for real-time updates on these metrics.

Meyka AI Rating and Price Forecast

Meyka AI rates HCLTECH.NS stock with a grade of B+, suggesting a Buy recommendation. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating reflects strong fundamentals despite recent price weakness.

Meyka AI’s forecast model projects HCLTECH.NS stock reaching ₹1,914.15 within one year, implying 59.7% upside from current levels. The three-year forecast stands at ₹2,201.37, while the five-year target reaches ₹2,486.10. These grades and forecasts are not guaranteed and we are not financial advisors. Earnings are scheduled for announcement on July 13, 2026.

Final Thoughts

HCLTECH.NS shows mixed signals with oversold RSI levels offset by bearish MACD indicators. Strong fundamentals including low debt and consistent earnings growth support a B+ rating. Despite weak year-to-date performance, the five-year return of 33.25% demonstrates solid long-term growth. The July 13, 2026 earnings announcement may trigger volatility given low trading volume. At 19.56 PE with dividend support, the stock offers reasonable IT sector exposure for patient investors.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.